receptors, dopamine d2

Preferred Label : receptors, dopamine d2;

MeSH definition : A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES.;

MeSH synonym : receptor, dopamine-d2; dopamine d2 receptors; dopamine d2 receptor; dopamine-d2 receptor; d2 receptors, dopamine;

MeSH annotation : DF: RECEPT DOPAMINE D2;

Wikipedia link : https://en.wikipedia.org/wiki/Dopamine d2 receptors;

Is substance : O;

Détails

Origin ID

D017448;

UMLS CUI

C0058698;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- physiology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
Currated CISMeF NLP mapping
- D(2) Dopamine Receptor [NCIt concept]
Indexing information
- 1-((2-phenylcyclopropyl)-methyl)-4-(2,4-dimethylphenyl)piperazine [MeSH Supplementary Concept]
- 1-((2-phenylcyclopropyl)methyl)-4-(2,4-dichlorophenyl)piperazine [MeSH Supplementary Concept]
- 1-((3-methylphenyl)piperazin-1-yl)-3-(thio(4-acetamido)phenyl)propane [MeSH Supplementary Concept]
- 1-ethyl-3-(2-(4-(3-methoxyphenyl)butyl)phenoxymethyl)piperidine [MeSH Supplementary Concept]
- 1-methyl-3-(2-(4-(3-methoxyphenyl)butyl)phenoxymethyl)piperidine [MeSH Supplementary Concept]
- 1-methyl-3-(2-(4-phenylbutyl)phenoxymethyl)piperidine [MeSH Supplementary Concept]
- 10,11-dihydroxy-N-n-propylnorapomorphine [MeSH Supplementary Concept]
- 1H-indole-2-carboxylic acid (4-(2-(cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl)cyclohexyl)amide [MeSH Supplementary Concept]
- 2,10,11-trihydroxy-N-propylnorapomorphine [MeSH Supplementary Concept]
- 2-((benzyl)propylamino)-5-methoxytetralin [MeSH Supplementary Concept]
- 2-amino-2,3,3a,4,5,6-hexahydro-1H-phenalene [MeSH Supplementary Concept]
- 2-chloro-N-n-propylnorapomorphine [MeSH Supplementary Concept]
- 3-(3,4-dimethylphenyl)-1-(2-piperidin-1-ylethyl)piperidine [MeSH Supplementary Concept]
- 3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine [MeSH Supplementary Concept]
- 3-(4-(2-(2-chlorophenyl)ethyl)-1-piperazinyl)-4,5-dihydro-1H-benzo(g)indazole [MeSH Supplementary Concept]
- 5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide 2-fumarate [MeSH Supplementary Concept]
- 5-hydroxy-2-(N-propyl-N-(5'-fluoropentyl))aminotetralin [MeSH Supplementary Concept]
- 5-hydroxy-2-(N-propyl-N-(5'-fluoropentyl))aminotetralin [MeSH Supplementary Concept]
- 7-(4-(3-(1H-inden-3-yl)propyl)piperazin-1-yl)-1,3-benzoxazol-2(3H)-one [MeSH Supplementary Concept]
- 7-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one [MeSH Supplementary Concept]
- 7-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one [MeSH Supplementary Concept]
- 8-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-4H-benzo(1,4)oxazin-2-methyl-3-one [MeSH Supplementary Concept]
- 9-(4-methylpiperazin-1-yl)pyrrolo(2,1-b)benzothiazepine [MeSH Supplementary Concept]
- CHF 1024 [MeSH Supplementary Concept]
- CLR151 [MeSH Supplementary Concept]
- GR 103691 [MeSH Supplementary Concept]
- N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine [MeSH Supplementary Concept]
- N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine [MeSH Supplementary Concept]
- N-methyl-N-n-propyl-2-amino-5-fluoro-6-hydroxy-1-phenyl-2,3-dihydro-1H-indene [MeSH Supplementary Concept]
- N-methyl-N-n-propyl-2-amino-6-fluoro-5-methoxy-1-phenyl-2,3-dihydro-1H-indene [MeSH Supplementary Concept]
- N-n-propylnorapomorphine [MeSH Supplementary Concept]
- N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate [MeSH Supplementary Concept]
- Pramipexole [MeSH Descriptor]
- S 32504 [MeSH Supplementary Concept]
- SDZ GLC 756 [MeSH Supplementary Concept]
- YKP 1358 [MeSH Supplementary Concept]
Record concept(s)
- receptors, dopamine D2 [MeSH concept]
Related MeSH Supplementary Concept(s)
- DOP-3 protein, C elegans [MeSH Supplementary Concept]
- DOP-4 protein, C elegans [MeSH Supplementary Concept]
- DRD2 protein, human [MeSH Supplementary Concept]
- DRD2 protein, mouse [MeSH Supplementary Concept]
- DRD2 protein, rat [MeSH Supplementary Concept]
- dop-2 protein, C elegans [MeSH Supplementary Concept]
- dopamine 2-like receptor, Drosophila [MeSH Supplementary Concept]
- dopamine D2 receptor alpha1B [MeSH Supplementary Concept]
- dopamine D2L receptor [MeSH Supplementary Concept]
Related MeSH term(s)
- Dopamine D2 Receptor Antagonists [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]
UMLS correspondences (same concept)
- D2 receptor [FMA entity]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients